Addressing Ethical and Procedural Principles for Unrelated Allogeneic Haematopoietic Progenitor Cell Donation in a Changing Medical Environment.

Transplantation of allogeneic haematopoietic progenitor cells (HPC), as part of a potential life-saving treatment for haematological disorders, is a well-established medical procedure. Due to the efforts of the World Marrow Donor Association (WMDA) and other professional medical and scientific organisations, donation and collection of HPC from adult volunteer donors has become suitably regulated and standardized. Ongoing changes in the treatment of haematological disorders however, have led to a practice where organisations providing HPC from volunteer donors are confronted with requests for multiple or other than standard bone marrow or peripheral blood stem cell donations.
Source: Biology of Blood and Marrow Transplantation - Category: Hematology Authors: Source Type: research